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Summary 
Pro and pre B cells possess the long-term capacity  to proliferate  in vitro on stromal cells and 
interleukin 7 (IL-7) and can differentiate  to surface immunoglobnlin (slg +) calls upon removal 
of IL-7 from the cultures. A  key event in this differentiation is the extensive cell loss due to 
apoptosis.  Because the proto-oncogene bcl-2 can promote cell survival, we established pre-B cell 
lines from E#-bcl-2 transgenic mice. These pre-B cells have the same properties as those derived 
from non-bcl-2 transgenic mice except that they do not die by apoptosis. This allowed us to 
study the fate of newly formed B cells in vitro for a longer period of time. Here we show that 
early during the differentiation of pre-B cells, upregulation of RAG-1 and RAG-2 expression 
go hand in hand with rearrangements of the Ig gene loci. Moreover,  the newly formed sIg + 
B cells continue to express RAG-1 and RAG-2 and continue to rearrange L chain gene loci, 
even in the absence of proliferation, in an orderly fashion, so that gL + sIg + cells can become 
XL + sIg + or slg- cells, whereas M, + slg + cells can become sIg-, but not KL + sIg + ceils. Thus, 
deposition of a complete Ig molecule on the surface of a B cell does not automatically stop the 
Ig-rearrangement machinery. 
T 
he bcl-2 gene encodes a 26-kD c~ protein and a/3 form of 
21 kD varying at the COOH-terminal end (1). The bcl-2 
protein is mainly expressed in B- and T-lymphocyte-lineage 
cells at defined stages of their differentiation (2-4).  It was 
originally identified as the locus translocated to the Ig H chain 
locus in the (t 14:18) (q32;q21) translocations found in most 
cases of human follicular lymphomas (5-9).  Translocations 
leave the coding regions intact but put the (onco)gene under 
the control of expression of the IgH locus, leading to consti- 
tutive high expression along the B-lineage pathway from early 
precursors to plasma cells. Although the exact functions of 
the bcl-2 gene are still unknown, it plays the role of rescuing 
cells from programmed cell death (apoptosis,  characterized 
by chromatin condensation and by endonucleolytic cleavage 
of DNA  into characteristic  nucleosome ladders)  (10, 11), 
thereby prolonging the lifespan of the cell in which it is ex- 
pressed.  This has been shown for B-lineage,  T-lineage, and 
other hematopoietic cells by transfection of the bd-2 gene 
(12, 13) and in bcl-2-transgenic (tg) 1 mice (14-20).  The bd-2 
expression pattern in normal T- and B-lymphoid lineage cells 
suggests that it may play a role in changing the life span of 
antigen-selected lymphocytes to longevity (21, 22). From all 
1 Abbreviations used in this paper: HU,  hydroxyurea;  slg, surface Ig; tg, 
transgenic. 
these studies it appeared reasonable to expect that constitutive 
bcl-2 expression in precursor (pre-) B cells of E#-bcl-2-tg-mice 
(16-18) would inhibit the apoptosis of B cells differentiating 
from long-term proliferating pre-B cells. This differentiation 
can be induced by removal of IL-7 from cultures of these pre- 
B cells which need stromal cells and IL-7 for continued prolifer- 
ation (23). 
This paper compares the differentiation of normal pre-B 
with bcl-2 tg pre-B cells in vitro to surface Ig + (slg +) and 
sIg- B ceUs. The results show that proliferation on stromal 
cells and IL-7, and differentiation of bcl-2 tg pre-B cells upon 
removal of IL-7, is normal except that the differentiated B 
cells do not die by apoptosis. This allows an investigation 
of the state of the sIg + and sIg- cells, generated by produc- 
tive and nonproductive, respectively, rearrangements of the 
H and L chain gene loci, their expression ofpre-B cell-specific 
and -related genes such as Vp~ and )~s (24), and RAG-1 and 
RAG-2 (25, 26), and their use of KL and XL chain gene loci 
during differentiation to sIg + B cells. 
Materials and Methods 
Animals and CelI Lines.  E#-bcl-2  transgenic mice originally ob- 
tained from Drs. A. Harris and S. Cory, (Walter and Eliza Hall 
Institute of Medical Research, Melbourne, Australia) and previ- 
ously described (16-18) were bred in the breeding fadlities of the 
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ascertained by the presence of SV-40 DNA sequences flanking the 
bcl-2 tg (16-18). The stromal cell line PA-6 was obtained from Dr. 
H. A. Kodama (Ohu University, Japan). PA-6 cells and 3T3 fibro- 
blasts transfected with the murine I1:7 cDNA were grown as de- 
scribed  (23). 
Interleukins, Monoclonal Antibodies, Irarnunofluorescence, and Flow 
Cytometric Analysis.  rib7, produced by the fibroblast cell line 3T3 
transfected with the mouse I1:7 gene, was used at a concentration 
of 50-200 U/ml. The FITC-, PE- or biotin-conjugated mAb RAB- 
6B2 (anti-B220), R26-46 (M  +  X2 L chains),  and 6C3 (anti-BP- 
1) were obtained from Pharmingen (San Diego, CA). The mAb 
$7 (anti-CD43),  Ack4 (anti-c-kit), M41 (anti-/zH chain), 187.1 (anti- 
KL chain), and 4/1-101 (anti-M chain) were purified from culture 
supematant and conjugated as previously described (23). Cell sur- 
face immunofluorescence and flow cytometric analyses were per- 
formed as described (27).  Cells expressing K or X L chains were 
sorted using the FACStar Plus  |  (Becton and Dickinson, Mountain 
View,  CA). 
Preparation of  Pre.B Cell Lines.  Pre-B cell lines that possess the 
long-term capacity to proliferate on stromal cells in the presence 
of I1:7 were prepared from day 17-18 fetal liver and from 2-wk-old 
bone marrow cells as previously described (23, 27). Throughout 
these experiments PA-6 cells were used as stromal cells. The influence 
of hydroxyurea on the proliferation and differentiation of our pre-B 
cells was studied using different concentrations. For proliferation, 
pre-B cell cultures were initiated at 5  x  104 cells/ml on PA-6 plus 
Ib7 in the presence of  different concentrations of hydroxyurea. Cell 
growth was determined by [3H]thymidine uptake during the last 
6 h of a 72-h culture period. For differentiation, pre-B cell cultures 
were initiated at 1-2  x  10  s cells/ml on PA-6 stromal cells without 
1I:7 and in the presence of different concentrations of hydroxyurea. 
Differentiation was  determined by measuring  slg + cells after a 
72-h culture period. 
Northern Blot and Dot Blot Analysis.  Total cellular KNA was 
extracted from cells with acid guanidinium-thiocyanate-phenol- 
chloroform (28). For Northern blot analysis 15 #g denatured total 
RNA per lane was fractionated on a 1.2% agarose-0.4  M formal- 
dehyde gel and then blotted onto Gene Screen Plus  |  nylon mem- 
branes (Du Pont-Biotechnology Systems NEN, Boston, MA) by 
downward alkaline blotting. For dot blot analysis, 15 #g total RNA 
was  denatured in  55%  formamide,  7%  formaldehyde, 50 mM 
NaH2PO4,  pH 7.2, for 10 rain at 65~  serially diluted in steps 
of three in the same buffer, and applied  to a Gene Screen Plus  | 
nylon  membrane  with  a  Unifold  |  96-well  blotting  apparatus 
(Schleicher  & Schuell,  Inc., Keene, NH) by gentle suction. The 
membrane was washed in 0.2 M NaH2PO4,  pH 7.2, for 10 min, 
in H20 (tridist.) for 2 min and air-dried. 
Filters  were prehybridized in 7% SDS,  1 mM EDTA, 0.5 M 
NaHzPO4, pH 7.2, for 4 h at 65~  and hybridized in the same 
buffer overnight at 65~  with cloned fragments of CK, VpreB1, 
RAG-2, and/~-actin genes in M13mp18, labeled by second strand 
synthesis in a reaction primed by a 17-met sequencing primer (New 
England Biolabs, Beverly, MA) and c~-[3zP]dCTP. The probe for 
CM was a kind gift of Dr. Shunichi ~keda in our Institute and 
was  labeled  using  a WQuick Prime  |  kit  (Pharmacia,  Uppsala, 
Sweden)  according to the manufacturer's protocol. 
Hybridized membranes were washed twice in 5% SDS, twice 
in 1% SDS, both in 40 mM NaH2PO4,  pH 7.2, 1 mM EDTA at 
65~  for 20 min each and were autoradiographed with a Kodak 
X-OMAT AR film (Eastman Kodak Co., Rochester, NY). Radio- 
activity on the blots was also visualized and quantified by means 
of a Phosphorlmager  |  with ImageQuant  |  software 3.0 (Molec- 
ular Dynamics, Inc., Sunnyvale, CA). Before rehybridization, blots 
were stripped of the hybridized radioactivity by washing the mem- 
branes four to five times in 0.01  x  SSC, 0.01% SDS at 95~  for 
2-3 min. 
RNA Isolation, cDNA Synthesis, and PCR.  BC1:2-5 cells were 
FACS  |  sorted after 5 d of differentiation and total RNA was iso- 
lated from 20,000 K  +,  2~+, or K§  -  cells. 
The cells were lysed in 100 #1 guanidinium-isothiocyanate solu- 
tion (28), 10/~12 M Na-acetate, pH 4, and 100/~1 phenol/chloro- 
form/isoamylalcoho125:24:1 (water saturated) were added, mixed 
(15 min, 4~  The upper phase was added to 120/~1 isopropanol 
and the RNA precipitated by centrifugation. The pellet was washed 
with 70%  ethanol, air dried, and resuspended in 20/~1 water. 
First strand synthesis  was carried out using random hexamer 
primers (Boehringer-Mannhdrn, Mannheim, FRG) and Superscript 
Reverse Transcriptase (GIBCO BRL, Basel, Switzerland) in a total 
volume of 20/~1. 
1/~1 of the cDNA preparation was subsequently used for PCR 
amplification.  The primers for RAG-1 and KAG-2 were kindly 
provided by Dr. G.-K. Sim, Basel Institute for Immunology, and 
had the following sequences:  RAG-1 5' CCAAGCTGCAGACA- 
TTCTAGCACTC; RAG-1 3' CAACATCTGCCTTCACGTCGA- 
TCC; RAG-2 5' CACATCCACAAGCAGGAAGTACAC; RAG- 
2 3' GGTTCAGC~ACATCTCCTACTAAG; The control primers 
for the housekeeping gene HPKT were kindly provided by Dr. M. V. 
Wiles, Basel Institute for Immunology. The sequences  are pub- 
lished (29). 
All primers were designed to be intron-spanning to distinguish 
DNA contamination. 
PCK reactions were performed on 1 #1 of the cDNA prepara- 
tion (i.e., RNA from 1,000 cells) in a total volume of 20 #1 ac- 
cording  to  the  enzyme manufacturer's  conditions  (Boehringer 
Mannheim). The temperature settings for the Perkin Elmer Cetus 
PCR Cycler (Norwalk, CT) were 94~  20 s, 58~  20 s, 72~ 
40 s for 35 cycles. 
Semiquantitative PCR Titration  for K Rearrangements.  BCL-2-5 
cells on days 0, 1, 2, 3, and 4 of differentiation were counted by 
Trypan blue exclusion, lysed by boiling, and DNA prepared as de- 
scribed dsewhere (27). DNA was diluted in threefold steps in 10 
mM Tris-C1, pH 8.3, leading to DNA equivalents  of 300,  100, 
30, 10, and 3 cells, respectively, per 5 #1 of the dilution. The PCR 
reaction was performed according to the enzyme manufacturer's 
conditions (Boehringer Mannheim) in a final volume of 20 #1. The 
PCR primers (universal V~ and J~2 primers detecting V~-J~l and 
V,-J,2 rearrangements) and reaction conditions are described else- 
where (30). 
Half of the resulting PCR product was separated  on a 1.5% 
agarose gel by electrophoresis.  Bands of 536 (V~-JA) and 130 bp 
(V,-J~2) were visualized  under UV light. 
l~sults 
Establishment of  Pre-B Cell Lines  from bcl-2 tg Mic~  Pre-B-I 
cells of normal mice can proliferate for long periods of time 
on stromal cells in the presence of IL-7 (23, for the nomen- 
clature of pre-B cells used by us see reference 24). To estab- 
lish pre-B-I cell lines from kl-2 tg mice, cell suspensions of 
fetal liver at day 17-18 of gestation and of bone marrow 2 
wk after birth were cultured under conditions  of limiting 
dilution on PA6 stromal cells in the presence of exogenously 
added IL-7. Growth of cells was scored at day 6 of culture, 
and lines and clones were established from positive cultures 
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Fetal liver cells were obtained from individual  embryos of 
crosses of mice heterozygous for the bd-2 tg and from bone 
marrow of bd-2 tg mice. The presence of the bcl-2 tg in pre-B 
cell lines was ascertained by the presence of SV-40 DNA se- 
quences flanking the bd-2 gene construct,  and was further- 
more evident from the unusual  survival capacity of cells in 
tissue culture upon differentiation as described below. Three 
bcl.2 transgenic cell lines (bd-2-1, bd-2-5, and bcl-2-6) were 
derived from fetal liver of three individual  embryos which 
were typed as  tg positive. 
Proliferation of bcl-2 tg pre-B cells on stromal cells in the 
presence of IL-7 was indistinguishable  from pre-B cells of 
normal mice in several parameters.  Both needed the simul- 
taneous presence of stromal cells and IL-7 for proliferation, 
both proliferated at the same rates and for the same long periods 
of time (data not shown). The frequencies of pre-B cells (1 
in  50 at day 17-18  of gestation  in  fetal liver;  1 in  50-100 
in 2-wk-old bone marrow) were within the ranges found for 
normal  cells. 
All kl-2 tg pre-B-I cell lines, just as those from normal 
mice,  expressed  mRNA  for  the  pre-B  cell-specific  genes 
Vr~eB, RAG-l, and RAG-2, but not KL and M. chain genes, 
as detected in Northern blot analyses (Fig.  1). They expressed 
CD43, c-kit, B220, and BP-1, but not slg (/z, r), as detected 
by immunofluorescence with specific mAbs. Pre-B-I cells from 
bcl-2 tg mice were found to be D,J.-rearranged  in their H 
chain  loci (data not  shown). 
We conclude that bcl-2 tg pro and pre-B-I cells have many 
of the properties  of normal  pre-B-I  cells. 
Differentiation ofbcl-2 tg Pre-B-I Cell Lines In Vitra  Differ- 
entiation  of normal pre-B-I cells occurs in vitro when IL-7 
is removed from tissue culture (23). Differentiating cells lose 
the capacity to grow on stromal cells in the presence of IL-7 
(23),  and  a  portion  of them  become  slg +  and  mitogen- 
reactive cells within 2-3 d (23, 31, 32). Normal cells die rap- 
idly by apoptosis, as evidenced by the endonucleolytic degra- 
dation  of DNA  and a loss of live cells (23). 
When IL-7 was removed from cultures of bcl-2 tg pre-B-I 
cell lines,  the cells lost the capacity to grow on stromal cells 
in the presence of IL-7, determined as frequencies ofclonable 
cells,  at a similar rate as pre-B-I cells of normal littermates 
(Fig.  2, bottom). In contrast to normal pre-B-I cells,  bcl-2 tg 
pre-B cells  did not die by apoptosis (Fig.  2,  top). Cells re- 
mained  viable  during  differentiation.  However,  the  vast 
majority of the cells changed their phenotype.  Within  3 d 
Figure  1.  Northern  blot (right)  and RNA dot blot (/eft) analysis  of undifferentiated and differentiating pre-B cell lines from Elz-bd-2-transgelfic  ~ocl 
2-5-4, bcl 2-5) and normal (C57BL/6 x  DBA/2)F1  mice (PAL.l). Pre-B cells were cultured and induced to differentiate as described  (23). RNA dot 
blots with serial threefold dilutions and Northern blots were performed with 15/zg total RNA. Blots were probed with 32P-labeled, subcloned  400- 
600-bp fragments of the genes RAG-l, RAG-2, Vv~,a, Cr, C)~1, and B actin as indicated in the figure. The size of the bands detected  by these probes 
is given in kb. Quantification of the signals was performed on a Phosphor Imager (Molecular Dynamics) with the Image Quant software  package 
supplied by the manufacturer. The expression level  of RAG-l, normalized to the signal for B-actin, increases 26-, 2.5-, and 18-fold  for bcl 2-5-4, bcl 
2-5, PAL.l, respectively,  within 2 d of differentiation. RAG-2 expression is upregulated 21-fold for bcl 2-5-4 and 2.0-fold for bcl 2-5 within 3 d of 
differentiation and 7.3-fold for PAL.1 after 2 d of differentiation. 
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Figure 2.  Survival (top) and cloning  frequencies on PA6 + IL-7 (bottom) 
of El~-kl-2 fetal liver-derived pre-B cell lines bcl-2-1 (~), bcl-2-5 (~), 
and bcl-2-6 (O) and the C57BL/6  x  DBA/2 F~ fetal liver-derived pre-B 
cell lines, PAL1 (I-7), 18L-2 (A), and PAB8 (I) after culture for 0-7 d 
on PA6 stromal ceils without Ib7. Viable cells were determined by Trypan 
blue exclusion. Cloning  frequencies were determined by limiting  dilution 
analysis with live cells as described (27). Positive pre-B cell growth was 
determined by the use of an inverted microscope at 6 d after onset of the 
cultures. Similar results were obtained with BM-derived pre-B cell lines. 
they lost surface expression of c-kit,  CD43, BP-1,  and the 
surrogate  L  chain  Vp~,B/X5. Fetal  liver-derived  cell  lines 
were indistinguishable in these differentiation capacities from 
bone marrow-derived cells (data not  shown). 
On the level of specific  RNA expression,  the surrogate 
L chain disappeared within 2-3 d, whereas expression of gL 
chain mENA became detectable after 2 d, and of XL chain 
mRNA after 3 d of differentiation (Fig. 1). Surprisingly, the 
expression of RAG-1 and RAG-2 mRNA actually increased 
for the first 2 d of in vitro differentiation,  before it began 
to decrease.  This increase was seen in El~-bcl-2-tg  as well as 
in normal cells.  Using a limiting dilution PCR, IgL chain 
rearrangements  were analyzed. About 1 in 300 cells at day 
0 had a rearrangement,  this was 1 in 100 at day 1, and more 
than  1 in  10 from day 2  of differentiation  onwards. 
Differentiation  to slg + B  Cells Expressing  Either  K or XL 
Chains.  Within 3 d of in vitro differentiation of normal as 
well as bcl-2 pre-B cells,  "~10% of all cells became sIg + . At 
the same time, >85% of the sIg + cells expressed KL chains 
(Fig.  3). Extensive apoptosis of the normal cells prevents an 
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Figure 3.  Kinetics of development of surface ~pression of#H (@) KL 
(O), M  +  X2 L (A), and ML (A) chains on El~-bcl-2 fetal liver-derived 
bcl-2-5 (solid lines) or C57BL/6  x  DBA/2 Fl-derived PAD1 (dotted lines) 
pre-B cells cultured for different times on PA6 only. Surface expression 
was determined as described (27). Similar results were obtained with other 
El~-bcl-2 fetal liver as well as bone marrow-derived  pre-B cells. 
analysis of cells which have differentiated in vitro for periods 
exceeding 3 d. Such an analysis could, however, be done with 
kl-2-tg cells. It is evident from the data shown in Fig. 3 that 
the  total  number  of slg +  B  cells increased  with  time  of 
differentiation  in vitro,  reaching  levels  of 40%  slg + cells, 
Furthermore, the ratio of KL chains versus XL chains expressed 
in these sIg + cells changed.  At 3 d  of in vitro differentia- 
tion it was near  5,  and at one week or later around 0.7. 
These results suggested that the differentiated cells might 
be capable of continuous, successive rearrangements in their 
K and SL chain gene loci. This was substantiated by the fact 
that  sorted ~L + sIg + and XL + slg + were still positive for 
RAG-1 and RAG-2 expression as determined by RT-PCR. 
Therefore, bcl-2-tg cells differentiated for 5 d in vitro were 
sorted for ~L +  slg +  and XL +  slg + cells.  Thereafter,  they 
were recultured in the absence of IL-7 for a further 3 d and 
then assayed again for ~L + slg + , XL + slg + , and slg-  cells. 
Of the KL + slg + cells,  about half remained KL + slg + cells, 
"10% became M, + slg + cells, and '~40% changed to slg- 
cells.  Of the XL + slg + cells  75-80%  remained  XL + slg + 
cells,  '~20-25%  became slg-  cells, whereas 1% or less be- 
came KL + slg + cells. Several experiments with different fetal 
liver- and bone marrow-derived E/~-bc/-2-tg pre-B cell lines 
yielded similar results. Taken together, these results indicate 
that the slg + B cells differentiated in vitro from bcl-2-tg, and 
probably also from normal pre-B cells, can continue to rear- 
range L  chain  gene loci. 
Differentiation  in the Presence of Hydroxyurea.  Hydroxyurea 
(HU)  inhibits  the  replication  of DNA  and,  thereby,  the 
proliferation of ceils. It was added to E#-bcl.2-tg  pre-B cells 
cultured on stromal cells in the presence or absence of IL-7 
to see whether it would inhibit pre-B cell proliferation, and 
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cells. Results in Fig. 4 show that HU at 10 -4 M  or higher 
completely inhibits proliferation as measured by uptake of 
radioactive thymidine. On the other hand, the proportion 
of slg + B cells differentiating at these high concentrations 
of HU remained constant. The development of gL*  slg + 
and XL + slg + B cells within 3 d in the presence 2  x  10-4 
M  HU yielded ratios of M. to KL chain-expressing slg + B 
cells indistinguishable from those obtained in the absence of 
HU (Fig. 3). The results collectively suggest that differenti- 
ation to slg + B cells and maybe even the continued rear- 
rangement of L chain gene loci can ocCUr in the absence of 
DNA synthesis and cell proliferation. 
Discussion 
Pre-B cells that possess the long-term capacity to proliferate 
on stromal cells and IL-7 can differentiate to sIg + B cells by 
removal of IL-7 from the culture system (23, 31, 32). So far, 
extensive apoptosis (23) has hampered a more detailed anal- 
ysis at the cellular and moleCUlar level during this differentia- 
tion. Here we show that constitutive expression of the bcl-2 
proto-oncogene in these pre-B cells can prevent this apop- 
toffs and therefore allows us to follow the fate of newly formed 
slg + B cells in vitro.  One important question concerning 
the relevance of these studies is whether constitutive expres- 
sion of the bcl-2 gene interferes with the normal pre-B cell 
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Figure 4.  Proliferation  and differentiation  ofbcl-2-5 pre B cells in the 
presenr.e  of  hydroxyurea.  Proliferation  ofbcl-2-5  pre B ceils  on PA6 stromal 
cells in the presence  (@) or absence  of I1--7 (A) and in the presence of 
~t concentrations  of hy~xyurea was determined  by [SH]tbymidine 
uptake as described  (23). The expression  of slgM was determined  at day 
3 of  culture  on PA6 strornal  cells  without  ID7 and in the presence  of  dhffe~e~t 
concentrations  of hydroxyurea  as described  (23). Similar  results were ob- 
tained with other (fetal liver- or bone marrow-desired)  EIz-bcl-2 pre-B 
cell lines. 
differentiation pathway. The findings that the pre-B cells de- 
rived from E#-bcl-2  transgenic mice show the properties as 
those derived from non-bcl-2 transgenic mice like: (a) loss 
of donability on stromal cells and IL-7 after removal of IL-7 
from the culture system; (b) loss of  markers like CD43, c-kit, 
BP-1, VpreB, and X5 during differentiation; (c) upregulation 
of RAG-1 and RAG-2 expression during differentiation; and 
(d)  identical  kinetics  for  the  appearance  of slg +  B  cells 
strongly argue that constitutive expression of bcl-2 does not 
interfere with the normal pre-B cell differentiation pathway. 
The x/X ratio of Ig molecules in the serum as well as that 
of membrane-bound Ig on B lymphocytes in mice is >10. 
These high ratios of g to ~ can be explained by a regulatory 
model, in which rearrangements at the X loci are postulated 
to commence only after the g loci have been exhaustively and 
nonproductively rearranged. This model is supported by the 
fact that most of the K chain-expressing B cells have their 
X chain genes in germline configuration, whereas in X chain- 
producing B cells, the g chain genes are frequently rearranged. 
(33-36). 
High g/h ratios can also be explained by stochastic models 
that postulate an intrinsic rearrangement activity which is 
higher for g than for X loci (36-39).  The stochastic model 
has recently gained support from studies with mice in which 
the Ig X  lOCUS  was inactivated (40-42). These studies demon- 
strate that rearrangements at the Ig X locus and the produc- 
tion of XL chain-expressing B cells can occur without rear- 
rangements at the Ig g loCUs. 
A third model argues that high K/X ratios in the periphery 
reflect antigen selection and stimulation and that newly gener- 
ated B cells have x/X ratios near unity (42). Our earlier pub- 
lished findings (31) as well as the data shown above have 
strongly argued against this model. We have shown that im- 
mature slg + B cells obtained from normal non-bcl-2 tg pre-B 
cells that differentiate in vitro in the absence of exogenous 
antigen have already g/X ratios of >10. 
Our findings described here support the scenario in which 
K gene rearrangements are initially preferred over ~, genes. 
However, when the immature B cells can survive longer, the 
chances for X chain gene rearrangements increase and conse- 
quently the ratio of Jc over X light chain-expressing B cells 
decreases. These and other findings (35-41) reaffLml  a stochastic 
model in which a higher intrinsic rearrangement activity of 
the g over the X gene loci appears to be responsible for the 
high K/X ratio found in normal mice. 
Secondary rearrangements can in principle occur at several 
Ig loci. Thus far, two examples of V.-gene replacement in 
which  an  akeady rearranged V,D,J.-rearranged  H  chain 
loCUs could be altered with a second V, gene have been de- 
scribed (43, 44). The ~cL chain locus has a series of V~c- and 
Jg-  segments that allow subsequent rearrangements in an 
already rearranged locus by inversion or deletion of  intervening 
sequences (45-48). In normal B cells, cirCUlar  DNAs of rear- 
ranged VJs have been demonstrated of which a large part 
is in-frame and thus potentially functional (49).  Moreover 
in the/LH, xL chain-expressing NFS-5 tumor cells, XL chain 
rearrangement may occur and thus ~r  chains can be exchanged 
1267  Rolink  r  al. by XL chains (50). Hence, the rearrangement  machinery of 
a B cell does not automatically stop after deposition of a com- 
plete Ig in the cell membrane. 
Secondary rearrangements,  also termed "receptor editing" 
(51, 52) could either silence unwanted specifidties and/or sal- 
vage B cells with new desirable specificities.  Recent studies 
(51,  52) using mice expressing an autoantibody as a trans- 
gene have shown that immature B cells in the bone marrow 
of these mice can be rescued after encounter with their au- 
toantigen by exchanging the transgenic L chain in the Ig mol- 
ecule with an endogenously encoded L chain. This L chain 
replacement is possible because these immature B cells still 
express RAG-1 and RAG-2 (51). On the other hand, cross- 
linking of slg on immature B cell lines from N-rayc-tg mice 
which express slg as well as RAG-1 and RAG-2 simultane- 
ously has been found to lead to a rapid and reversible down- 
regulation of RAG-1 and RAG-2 expression (53). Therefore, 
occupancy of slg on (immature?)  B cells can either down- 
regulate (at least in N-myc-tg mice), or preserve (at least in 
autoantibody-tg mice) the expression of RAG-1 and RAG-2 
and, consequently, the capacity to express another L chain. 
This indicates that the signals given to an immature B cell 
via slg, as in mature B cells, can result in different reactions 
of these cells.  It remains  to be seen how the mode of Ig- 
receptor occupancy, additional cell contacts with the antigen- 
presenting environment,  and secondary signals by cytokines 
influence these reactions. 
Ongoing Ig gene rearrangements in slg + B cells are likely 
to generate B cells with more than one antibody specificity. 
In practice,  this may be avoided by the rapid  apoptosis of 
the immature B cells which leaves little time for secondary 
rearrangements, before the cells die, or before they are selected 
into the peripheral pool of mature B cells.  This might also 
be the reason for the fact that the rescued peripheral B cell 
pool in mice with transgenic H and L chain genes encoding 
an autoantibody is relatively small (51).  These scenarios of 
early B cell development are reminiscent of similar stages of 
T cell development, where immature c~/~ TcR + thymocytes 
keep expressing RAG-1 and RAG-2 and continue to rear- 
range c~ chain gene loci until they are positively selected into 
the pool of MHC-restricted CD4 + or CD8 + T cells (54, 55). 
Immature lymphocytes from E#-bcl-2-tg mice of both T 
and B cell lineages appear suitable target cells to study the 
cellular and molecular requirements of positive selection into 
the peripheral,  long-lived pools of cells. 
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